ÂÜÀòÂÒÂ×

Hui Lei is a seasoned professional in the field of chemistry, currently serving as Senior Vice President of Chemistry at Structure Therapeutics since August 2019, after holding the position of Vice President of Chemistry. Prior experience includes leading chemistry departments at Jing Medicine Technology and Eli Lilly China, where Hui Lei focused on drug discovery in oncology, immunology, and neuroscience. With a strong background in medicinal chemistry, Hui Lei has directed teams, overseen multiple technology platforms, and established collaborative models to translate academic research into viable drug discovery projects. Educational qualifications include a B.S. in Chemistry from Peking University and a Ph.D. in Chemistry from the University of Illinois Chicago.